Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122522) titled 'Telitacicept Combined with Glucocorticoids for the Treatment of Non-severe ANCA-associated Glomerulonephritis: A Multicenter Pilot Clinical Trial' on April 14.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Condition:
ANCA-associated Glomerulonephritis
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-04-15
Target Sample Size: treatment group:26;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=318562
Disclaimer: Curated b...